Latest Series C+ Funding Rounds

Later-stage rounds, from Series C onwards, for companies expanding products, distribution and operations.

This page showsStage: Series C+
Rounds
429
All time
Disclosed funding
$109.8B
386 disclosed amounts
Median round
$120M
Of disclosed amounts
429 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
VulcanFormsIndustrial tech · United StatesCompany profile

Develops integrated digital metal manufacturing platform

Develops integrated digital metal manufacturing platform

$220MSeries DSeries C+Industrial techUnited StatesInvestors
RobCoIndustrial tech · GermanyCompany profile

Develops AI-driven robotic systems for industrial automation and autonomy

Develops AI-driven robotic systems for industrial automation and autonomy

$100MSeries CSeries C+Industrial techGermanyInvestors
AutomataIndustrial tech · United KingdomCompany profile

Builds AI-ready lab automation platforms for life sciences

Builds AI-ready lab automation platforms for life sciences

$45MSeries CSeries C+Industrial techUnited KingdomInvestors
DecagonEnterprise software · United StatesCompany profile

Provides conversational AI agents for concierge customer experiences

Provides conversational AI agents for concierge customer experiences

$250MSeries DSeries C+Enterprise softwareUnited StatesInvestors
CellaresBiotech · United StatesCompany profile

Develops automated cell therapy manufacturing platforms

Develops automated cell therapy manufacturing platforms

$257MSeries DSeries C+BiotechUnited StatesInvestors
Redwood MaterialsClimate tech · United StatesCompany profile

Recycles batteries and produces cathode materials for energy storage

Recycles batteries and produces cathode materials for energy storage

$425MSeries ESeries C+Climate techUnited StatesInvestors
MeshFintech · United StatesCompany profile

Builds the universal crypto payments network

Builds the universal crypto payments network

$75MSeries CSeries C+FintechUnited StatesInvestors
AntheiaBiotech · United StatesCompany profile

Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients.

Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients.

$24MSeries C second closeSeries C+BiotechUnited StatesInvestors
Fiddler AIAI · United StatesCompany profile

Provides AI observability and security platform for enterprises

Provides AI observability and security platform for enterprises

$30MSeries CSeries C+AIUnited StatesInvestors
SynthesiaAI · United KingdomCompany profile

Develops AI-powered digital avatars for corporate clients

Develops AI-powered digital avatars for corporate clients

$200MSeries ESeries C+AIUnited KingdomInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    Andreessen Horowitz (a16z)

    ASI, Labelbox, Valon

    36rounds
    3led
  2. 2
    Sequoia Capital

    Whop, Blacksmith, Abby Care

    32rounds
    3led
  3. 3
    General Catalyst

    Tractian, Legora, Modal Labs

    29rounds
    0led
  4. 4
    Lightspeed

    Enveda, Snorkel AI, Profound

    28rounds
    3led
  5. 5
    Y Combinator (YC)

    Tractian, Blacksmith, Jeeves

    22rounds
    0led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic